Page 3 - Gamida Cell News Today

Operator: Ladies and gentlemen, thank you for standing by. Welcome to Gamida Cells Conference Call for Third Quarter 2023 Financial Results.

Gamida Cell (NASDAQ:GMDA – Get Free Report) will announce its earnings results before the market opens on Tuesday, November 14th. Analysts expect the company to announce earnings of ($0.15) per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link. Gamida Cell (NASDAQ:GMDA – Get Free […]

Gamida Cell Ltd. shared new data on the impact of the company?s proprietary nicotinamide technology on its allogeneic stem cell therapy omidubicel and investigational natural killer cell therapy...

BOSTON, Nov. 04, 2023 -- Gamida Cell Ltd. , a cell therapy pioneer working to turn cells into powerful therapeutics, today shared new data on the impact of the company’s proprietary nicotinamide ...

Data further characterize the mechanism for Gamida Cell’s proprietary nicotinamide (NAM) technology’s expansion and enhancement of cells...

Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The

Gamida Cell (NASDAQ:GMDA – Get Free Report) and SQZ Biotechnologies (NYSE:SQZ – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, institutional ownership, risk, valuation and dividends. Earnings and Valuation This table compares Gamida […]

Data show promising early evidence of anti-tumor activity in patients with relapsed/refractory B cell non-Hodgkin lymphoma Full data readout of Phase 1 study expected in Q1 2024 ...

Gamida Cell Ltd. , a cell therapy pioneer working to turn cells into powerful therapeutics, today issued an update on its operations in Israel. “We remain profoundly saddened by the attacks in...

Gamida Cell Statement Regarding Attacks on Israel October 7, 2023 October 7, 2023 - We condemn the brutal and unprovoked attacks on Israel...